Valorian Technologies
First-of-its-kind technology to solve a widespread unmet need in men’s health.
Solving erectile dysfunction at the root
Dynamic Adaptability, Superior Efficacy
Valorian Medical Technologies is the latest company to spin out of Expanse. With the support of the Rhode Island Life Science Hub (RILSH), Valorian Medical Technologies will leverage Expanse’s full-cycle product development to tackle large clinical gaps in men’s health, including erectile dysfunction. After a successful clinical proof-of-concept, Valorian will develop the next-generation device for patients who fail to respond to PDE5i’s. Current solutions are invasive, painful, or ineffective. Valorian’s technology will redefine the market.
- 52% of men 40-70 years old suffer from erectile dysfunction
- 50% of patients cannot take or respond poorly to PDE5i’s
